$3.76
25.17% today
Nasdaq, Jul 14, 07:11 pm CET
ISIN
US2307701092
Symbol
CPIX
Sector
Industry

Cumberland Pharmaceuticals Inc. Stock price

$3.00
-2.67 47.09% 1M
+0.67 28.76% 6M
+0.63 26.58% YTD
+1.56 108.33% 1Y
+0.78 35.14% 3Y
-0.20 6.25% 5Y
-4.23 58.51% 10Y
-13.83 82.17% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
-0.34 10.18%
ISIN
US2307701092
Symbol
CPIX
Sector
Industry

Key metrics

Basic
Market capitalization
$44.9m
Enterprise Value
$35.0m
Net debt
positive
Cash
$15.1m
Shares outstanding
15.0m
Valuation (TTM | estimate)
P/E
negative | -
P/S
1.1 | -
EV/Sales
0.9 | -
EV/FCF
6.7
P/B
1.6
Financial Health
Equity Ratio
30.2%
Return on Equity
-28.4%
ROCE
-7.4%
ROIC
-10.9%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$41.1m | -
EBITDA
$1.4m | -
EBIT
$-3.3m | -
Net Income
$-3.3m | -
Free Cash Flow
$5.2m
Growth (TTM | estimate)
Revenue
5.8% | -
EBITDA
126.1% | -
EBIT
66.9% | -
Net Income
61.0% | -
Free Cash Flow
4.0%
Margin (TTM | estimate)
Gross
84.3%
EBITDA
3.3% | -
EBIT
-8.0%
Net
-8.0% | -
Free Cash Flow
12.7%
More
EPS
$-0.2
FCF per Share
$0.4
Short interest
0.8%
Employees
91
Rev per Employee
$420.0k
Show more

Is Cumberland Pharmaceuticals Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Cumberland Pharmaceuticals Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Cumberland Pharmaceuticals Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Cumberland Pharmaceuticals Inc. forecast:

Hold
50%
Sell
50%

Financial data from Cumberland Pharmaceuticals Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
41 41
6% 6%
100%
- Direct Costs 6.44 6.44
1% 1%
16%
35 35
7% 7%
84%
- Selling and Administrative Expenses 28 28
2% 2%
69%
- Research and Development Expense 4.95 4.95
10% 10%
12%
1.37 1.37
126% 126%
3%
- Depreciation and Amortization 4.64 4.64
0% 0%
11%
EBIT (Operating Income) EBIT -3.27 -3.27
67% 67%
-8%
Net Profit -3.28 -3.28
61% 61%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Cumberland Pharmaceuticals Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cumberland Pharmaceuticals Inc. Stock News

Neutral
PRNewsWire
21 days ago
New pharmacokinetic and cardiac biomarker data further demonstrate ifetroban's potential to protect the heart and reduce cardiac damage in DMD patients NASHVILLE, Tenn. , June 23, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company committed to developing new products for rare diseases, shared the latest positive results from its Phase 2 FIGHT...
Neutral
PRNewsWire
about 2 months ago
Analysis Shows 23% Reduction in Morphine Use with Favorable Safety Profile in Patients 60 Years of Age and Older NASHVILLE, Tenn. , May 27, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the publication of its study investigating Caldolor® (intravenous ibuprofen) in older patients.
Neutral
PRNewsWire
2 months ago
Cumberland leveraging Qureight's deep-learning AI platform  for its Phase II FIGHTING FIBROSIS™ clinical trial NASHVILLE, Tenn. and CAMBRIDGE, England , May 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced a partnership with Qureight, a Core Imaging Labo...
More Cumberland Pharmaceuticals Inc. News

Company Profile

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

Head office United States
CEO A. Kazimi
Employees 91
Founded 1999
Website www.cumberlandpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today